Total 141054 resultPre Next
OrbiMed haalt $4,3 miljard op bij private investeringsfondsen By:OrbiMed 2023-10-25
NEW YORK, 24 oktober 2023 - OrbiMed, een wereldwijde beleggingsonderneming in de gezondheidszorg, kondigt verheugd aan dat het meer dan $ 4,3 miljard aan toezeggingen heeft opgehaald voor zijn nieuwste private investeringsfondsen, waaronder...
Q32 Bio Appoints Saul Fink, Ph.D. as Chief Technology Officer By:Q32 Bio 2023-10-25
WALTHAM, Mass., Oct. 24, 2023 - Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, today announced the appointment of Saul Fink, Ph.D., as Chief Technology Officer. Dr. Fink&...
LifeSpan Vision Ventures investit dans Matter Bio By:LifeSpan Vision Ventures 2023-10-25
NORWALK, Connecticut, 24 octobre 2023 - LifeSpan Vision Ventures a annoncé aujourd'hui un investissement dans Matter Bio, une société de gestion de portefeuille axée sur la longévité et la préservation de l'intégrité du génom...
Associated Banc-Corp Announces Increase in Common Stock Dividend By:Associated Banc-Corp 2023-10-25
GREEN BAY, Wis., Oct. 24, 2023 - The Board of Directors of Associated Banc-Corp (NYSE: ASB) ("Associated") today declared a regular quarterly cash dividend of $0.22 per common share, payable on December 15, 2023, to ...
Palatin Announces Closing of $5 Million Registered Direct Offering By:Palatin Technologies, Inc. 2023-10-25
CRANBURY, N.J., Oct. 24, 2023 - Palatin Technologies, Inc. (NYSE American: PTN) ("Palatin" or the "Company"), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the&nbs...